PHARMAID Stock Overview
Engages in the manufacturing of neutral glass ampoules in Bangladesh and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Pharma Aids Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ৳675.10 |
| 52 Week High | ৳819.80 |
| 52 Week Low | ৳579.00 |
| Beta | 0.067 |
| 1 Month Change | -11.69% |
| 3 Month Change | -2.23% |
| 1 Year Change | -14.62% |
| 3 Year Change | 71.69% |
| 5 Year Change | 15.60% |
| Change since IPO | 33,655.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHARMAID | BD Packaging | BD Market | |
|---|---|---|---|
| 7D | -0.2% | -7.2% | 0.01% |
| 1Y | -14.6% | 55.5% | -24.8% |
Return vs Industry: PHARMAID underperformed the BD Packaging industry which returned 55.5% over the past year.
Return vs Market: PHARMAID exceeded the BD Market which returned -24.8% over the past year.
Price Volatility
| PHARMAID volatility | |
|---|---|
| PHARMAID Average Weekly Movement | 5.4% |
| Packaging Industry Average Movement | 6.5% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in BD Market | 8.0% |
| 10% least volatile stocks in BD Market | 3.2% |
Stable Share Price: PHARMAID has not had significant price volatility in the past 3 months.
Volatility Over Time: PHARMAID's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 79 | Faizul Hassan | www.pharmaaids.com |
Pharma Aids Limited engages in the manufacturing of neutral glass ampoules in Bangladesh and internationally. The company’s neutral glass ampoules are used by pharmaceutical companies for filling liquid injections. The company was incorporated in 1981 and is headquartered in Dhaka, Bangladesh.
Pharma Aids Limited Fundamentals Summary
| PHARMAID fundamental statistics | |
|---|---|
| Market cap | ৳2.11b |
| Earnings (TTM) | ৳50.75m |
| Revenue (TTM) | ৳408.99m |
41.5x
P/E Ratio5.2x
P/S RatioIs PHARMAID overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHARMAID income statement (TTM) | |
|---|---|
| Revenue | ৳408.99m |
| Cost of Revenue | ৳288.26m |
| Gross Profit | ৳120.73m |
| Other Expenses | ৳69.97m |
| Earnings | ৳50.75m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 16.27 |
| Gross Margin | 29.52% |
| Net Profit Margin | 12.41% |
| Debt/Equity Ratio | 1.1% |
How did PHARMAID perform over the long term?
See historical performance and comparison